Nanosonics Wins Second FDA Clearance, Expanding CORIS Endoscope Range
NAN: $2.78 -2.46% · MC: $841M
Nanosonics has secured a second FDA clearance for CORIS, extending the system to additional endoscopes, including high-volume colonoscopes and gastroscopes. The clearance builds on earlier regulatory approvals and advances the company’s planned US launch and broader effort to expand CORIS indications.

Comments